NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 41 filers reported holding NEUROPACE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,072,591 | +234.0% | 110,209 | +54.1% | 0.00% | – |
| Q2 2023 | $321,102 | -3.2% | 71,515 | 0.0% | 0.00% | – |
| Q1 2023 | $331,829 | +312946.2% | 71,515 | 0.0% | 0.00% | – |
| Q4 2022 | $106 | -100.0% | 71,515 | +9.1% | 0.00% | – |
| Q3 2022 | $245,000 | -24.4% | 65,570 | 0.0% | 0.00% | – |
| Q2 2022 | $324,000 | -66.2% | 65,570 | -43.9% | 0.00% | – |
| Q1 2022 | $959,000 | -19.9% | 116,868 | -1.7% | 0.00% | – |
| Q4 2021 | $1,198,000 | -35.9% | 118,856 | +0.8% | 0.00% | – |
| Q3 2021 | $1,869,000 | -29.2% | 117,960 | +6.3% | 0.00% | – |
| Q2 2021 | $2,640,000 | – | 110,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 5,621,111 | $27,824,000 | 39.09% |
| Revelation Capital Management, LLC | 248,127 | $1,228,000 | 17.38% |
| Soleus Capital Management, L.P. | 2,334,003 | $11,553,000 | 1.80% |
| Orbimed Advisors | 4,012,281 | $19,861,000 | 0.36% |
| Opaleye Management Inc. | 90,100 | $446,000 | 0.20% |
| Nantahala Capital Management | 478,438 | $2,368,000 | 0.12% |
| Bellevue Group AG | 507,930 | $2,514,000 | 0.04% |
| Ergoteles LLC | 34,800 | $172,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 26,148 | $129,000 | 0.00% |
| Point72 Asset Management, L.P. | 149,199 | $739,000 | 0.00% |